The Advance in Important Target Proteins

Author(s): Yongtao Duan , Hailiang Zhu .

Journal Name: Current Topics in Medicinal Chemistry

Volume 19 , Issue 15 , 2019

Become EABM
Become Reviewer

[1]
Lv, P-C.; Yang, Y-S.; Wang, Z-C. Recent progress in the development of small molecule c-Met inhibitors. Curr. Top. Med. Chem., 2019, 19(15), 1276-1288.
[2]
Duan, Y. liu, W.; Tian, L.; Mao, Y.; Song, C. Targeting tubulin-colchicine site for cancer therapy: Inhibitors, antibody-drug conjugates and degradation agents. Curr. Top. Med. Chem., 2019, 19(15), 1289-1304.
[3]
Hu, Y.S.; Han, X.; Liu, X.H. STAT3: A potential drug target for tumor and inflammation. Curr. Top. Med. Chem., 2019, 19(15), 1305-1317.
[4]
Guo, W-Y.; Zeng, S-M-Z.; Deora, G.S.; Li, Q-S.; Ruan, B-F. Estrogen receptor α (ERα)-targeting compounds and derivatives: Recent advances in structural modification and bioactivity. Curr. Top. Med. Chem., 2019, 19(15), 1318-1337.
[5]
Sun, Z-G.; Liu, J-H.; Zhang, J-M.; Qian, Y. Research progress of Axl inhibitors. Curr. Top. Med. Chem., 2019, 19(15), 1338-1349.
[6]
Sun, P.; Zhang, S-J.; Maksim, S.; Yao, Y-F.; Liu, H-M.; Du, J. Epigenetic modification in macrophages: A promising target for tumor and inflammation-associated disease therapy. Curr. Top. Med. Chem., 2019, 19(15), 1350-1362.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 15
Year: 2019
Page: [1275 - 1275]
Pages: 1
DOI: 10.2174/156802661915190827162456

Article Metrics

PDF: 14
HTML: 5
EPUB: 1
PRC: 1